According to primary trials in T2DM, tirzepatide significantly reduces clinical outcomes like body weight, glycated hemoglobin (HbA1c), lipid profiles, and glucose-adjusted glucagon secretion compared to typical glucagon-like peptide1 receptor agonists (GLP1RAs) [1, 2]
Ten years later, a synthetic version of a hormone in the venom became the first medicine of its kind approved to treat type 2 diabetes
Its available as a generic for under $10 per month at most pharmacies and has decades of safety data
Animal lung phosphatidylcholine, for example, contains a high proportion of dipalmitoylphosphatidylcholine
According to a population-based study in Norway, adult women with type 1 diabetes have a twofold higher risk of having hypothyroidism, while men have a fourfold higher risk
Market Segment This study forecasts revenue at Spain, regional, and country levels from 2020 to 2033